title: Irritable bowel syndrome.
abstract: Within the literature, it appears evident that neither a univariate etiologic model nor a single-agent treatment approach is sufficient to address the many diagnostic, assessment, and therapeutic challenges posed by irritable bowel syndrome (IBS). Various scientific advances have been made over the past 5 years, particularly in the areas of nonpharmacologic management of IBS. However, further collaboration between scientists and clinicians from multiple disciplines is strongly encouraged.
authors.affiliation: Department of Family Medicine, Oklahoma State University College of Osteopathic Medicine, 1111 W. 17th Street, Tulsa, OK 74107-1898, USA. smturne@osu-com.okstate.edu
authors.forename: S M
authors.initials: SM
authors.lastname: Turner
authors.forename: J E
authors.initials: JE
authors.lastname: Stewart
authors.forename: J J
authors.initials: JJ
authors.lastname: Alexopulos
authors.forename: J S
authors.initials: JS
authors.lastname: Hill
mesh_terms: D003109:Colonic Diseases, Functional / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans